Evidence map›Paper›PMID 40176842›Full record

ArticleMolecular syndromology2025

Phenotypic Delineation of Combined Oxidative Phosphorylation Deficiency-12: Clinical Features of 2 Patients.

Meral Bahar Ister, Muge Cinar, Serdar Ceylaner, Ozlem Unal Uzun

Abstract read
In one paragraph

Article in Molecular syndromology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meral Bahar IsterFaculty of Medicine, Pediatric Metabolism, Kocaeli University, Kocaeli, Turkey.
Muge CinarFaculty of Medicine, Pediatric Metabolism, Kocaeli University, Kocaeli, Turkey.
Serdar CeylanerIntergen Genetics and Rare Diseases Diagnosis, Research and Application Center, Ankara, Turkey.
Ozlem Unal UzunFaculty of Medicine, Pediatric Metabolism, Kocaeli University, Kocaeli, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Combined oxidative phosphorylation deficiency-12 (COXPD12) is a rare autosomal recessive disorder. Neurological findings and lactic acidosis can be presenting signs of COXPD12. Case Presentation: Here, we present identical dysmorphic facial features that have not been described before in the literature, in 2 patients with two different Conclusion: For COXPD12 disease, facial features are considered the main diagnostic clue, such as hypotonia or lactic acidosis; thus, the characteristic facial phenotype will help clinicians diagnose the disease.

Indexed as

EARS2Facial dysmorphiaLactic acidosisOxidative phosphorylation

Identifiers

PMID40176842
PMCPMC11961135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.